Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 242Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Creon

02 2Creon

03 1Zenpep

PharmaCompass

01

Brand Name : Creon

arrow
Cancer Research
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Disorders

Currency : USD

2020 Revenue in Millions : 1,114

2019 Revenue in Millions : 1,041

Growth (%) : 7

Abbvie Company Banner

02

Brand Name : Creon

arrow
Immuno-Oncology 360
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Disorders

Currency : USD

2021 Revenue in Millions : 1,191

2020 Revenue in Millions : 1,114

Growth (%) : 7

Abbvie Company Banner

03

Brand Name : Creon

arrow
Immuno-Oncology 360
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Diseases

Currency : USD

2022 Revenue in Millions : 1,278

2021 Revenue in Millions : 1,191

Growth (%) : 7

Abbvie Company Banner

04

Brand Name : Creon

arrow
Immuno-Oncology 360
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Disease

Currency : USD

2015 Revenue in Millions : 516

2014 Revenue in Millions : 632

Growth (%) : 22%

Abbvie Company Banner

05

Brand Name : Creon

arrow
Immuno-Oncology 360
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Diseases

Currency : USD

2023 Revenue in Millions : 1,268

2022 Revenue in Millions : 1,278

Growth (%) : -1

Abbvie Company Banner

06

Brand Name : Creon

arrow
Immuno-Oncology 360
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Diseases

Currency : USD

2017 Revenue in Millions : 831

2016 Revenue in Millions : 730

Growth (%) : 14

Abbvie Company Banner

07

Brand Name : Creon

arrow
Immuno-Oncology 360
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Diseases

Currency : USD

2016 Revenue in Millions : 730

2015 Revenue in Millions : 632

Growth (%) : 16

Abbvie Company Banner

08

Brand Name : Creon

arrow
Immuno-Oncology 360
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Diseases

Currency : USD

2018 Revenue in Millions : 928

2017 Revenue in Millions : 831

Growth (%) : 12%

Abbvie Company Banner

09

Brand Name : Creon

arrow
Cancer Research
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Disorders

Currency : USD

2019 Revenue in Millions : 1,041

2018 Revenue in Millions : 928

Growth (%) : 12

Abbvie Company Banner

10

Brand Name : Creon

arrow
Cancer Research
Not Confirmed

Pancrelipase

Main Therapeutic Indication : Rare Disease

Currency : USD

2014 Revenue in Millions : 25.20%

2013 Revenue in Millions :

Growth (%) :

Abbvie Company Banner